OraSure Technologies | OSUR - Cost Of Sales


OraSure Technologies reported $15.43M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Agilent USD 845M 7M Mar/2026
AngioDynamics USD 37.29M 786K Sep/2025
Becton, Dickinson and Co. USD 2.56B 281M Mar/2026
Bio Techne USD 103.13M 1.47M Mar/2026
Bio-Rad Laboratories USD 282.7M 65.3M Mar/2026
Bruker USD 422.5M 21.1M Jun/2026
Cerus USD 23.42M 3.61M Dec/2024
Charles River Laboratories USD 716.51M 5.76M Mar/2026
Danaher USD 2.65B 294M Jun/2026
Dentsply International USD 453M 65M Mar/2026
Dexcom USD 478.4M 36.8M Jun/2026
Illumina USD 389M 19M Jun/2026
Integra LifeSciences USD 188.86M 10.15M Jun/2026
Intuitive Surgical USD 931.9M 8.4M Jun/2026
IQVIA Holdings USD 3.22B 141M Jun/2026
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Mettler Toledo International USD 396.52M 14.4M Jun/2026
Myriad Genetics USD 63M 1.1M Dec/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Quidel USD -79.5M 528.3M Mar/2026
Repligen USD 94.09M 8.12M Jun/2026
Revvity USD 323.46M 26.93M Mar/2026
STAAR Surgical USD 24.66M 10.6M Mar/2026
Thermo Fisher Scientific USD 7.54B 577M Jun/2026
Trinity Biotech USD 7.17M 666K Dec/2025
Waters USD 725M 350.06M Mar/2026